Epacadostat, Cladribine and Cytarabine (ECC) in AML
Clinical trial NCT03491579 · WITHDRAWN
Trial details
- NCT number
- NCT03491579
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2019-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.